PLXS (Plexus) 1-Year Sharpe Ratio: 2.08 (As of Jul. 09, 2026)


PLXS Plexus Corp PLXS
85 GF Score
Price $265.77
GF Value $149.54
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Plexus 1-Year Sharpe Ratio?

Plexus PLXS +3.89% 85 1-Year Sharpe Ratio is 2.08 as of Jul. 09, 2026. GuruFocus rates PLXS with a GF Score™ of 85/100 and a GF Value™ of $149.54 (Significantly Overvalued). The stock has 2 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-09), Plexus's 1-Year Sharpe Ratio is 2.08.


Plexus  (NAS:PLXS) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


Plexus 1-Year Sharpe Ratio Related Terms


PLXS vs RAL, BELFB, OLED: 1-Year Sharpe Ratio Comparison

For the Electronic Components subindustry, Plexus's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Plexus 1-Year Sharpe Ratio vs Hardware Industry

For the Hardware industry and Technology sector, Plexus's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where Plexus's 1-Year Sharpe Ratio falls into.


PLXS
85GF Score
Plexus Corp PLXS
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Plexus 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of 2.08 mean?
Plexus (PLXS) has a 1-Year Sharpe Ratio of 2.08 as of Jul. 09, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Plexus and its competitors.
Is Plexus' 1-Year Sharpe Ratio too high?
Plexus' current 1-Year Sharpe Ratio is 2.08. Overall, Plexus has a GF Score™ of 85/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Plexus' 1-Year Sharpe Ratio compare to RAL and BELFB?
Plexus' 1-Year Sharpe Ratio of 2.08 can be compared against companies in the Hardware industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Hardware company?
A good 1-Year Sharpe Ratio depends on the Hardware industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for Plexus and its competitors. Plexus's current 1-Year Sharpe Ratio is 2.08. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Plexus stock overvalued right now?
Based on GuruFocus' analysis, Plexus (PLXS) is currently considered Significantly Overvalued. The stock's GF Value™ is $149.54, compared to a current price of $265.77 — trading 77.7% above its estimated fair value. The current 1-Year Sharpe Ratio is 2.08. Plexus' overall GF Score™ is 85/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For Plexus (PLXS), the current 1-Year Sharpe Ratio is 2.08 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Plexus (PLXS) Overvalued in 2026?

Based on GuruFocus' analysis, Plexus stock appears to be overvalued. The current stock price of $265.77 is trading 77.7% above its estimated GF Value™ of $149.54. GuruFocus considers Plexus to be Significantly Overvalued.

Key valuation signals for PLXS:

  • 1-Year Sharpe Ratio: 2.08
  • GF Value™: $149.54 vs. price of $265.77 (77.7% above fair value)
  • GF Score™: 85/100 with 2 warning signs

No single metric tells the full story. See the PLXS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Plexus Business Description

Other Exchanges PX4:Germany
Address One Plexus Way, P.O. Box 156, Neenah, WI, USA, 54956
Plexus Corp designs, manufactures, and services complex products in demanding regulatory environments, supporting life-saving medical devices, mission-critical aerospace and defense products, industrial automation systems, and semiconductor capital equipment. Its integrated lifecycle solutions span design and development, supply chain solutions, new product introduction, manufacturing, and sustaining services for market and disruptive companies in the Aerospace/Defense, Healthcare/Life Sciences, and Industrial sectors. The Company operates through three reportable segments: AMER, APAC, and EMEA, with the majority of revenue from the APAC segment.
85GF Score

Get the complete analysis for PLXS

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$265.77
Price
$149.54
GF Value